MATHEW KIIO: Open Payments
NPI 1457704819 · LAWRENCE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 12 payments from 5 companies in 2025. Trend: 2023 $447 · 2024 $120 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $135 |
| Teva Pharmaceuticals USA, Inc. | 2 | $68 |
| Janssen Pharmaceuticals, Inc | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
Products named: VRAYLAR, AUSTEDO XR, SPRAVATO, CAPLYTA, REXULTI.
Industry payments across MA — which companies pay providers there.
